Return to Trial Database

HCRN-GI91-1

Phase I/II Study of Weekly Oral MTX + AZT in the Treatment of Metastatic Adenocarcinoma of the Pancreas and Hepatoma – GI91-1

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Phase I-II Study of Zidovudine (AZT) and Methotrexate (MTX) in Advanced Pancreatic Cancer and Hepatoma

Phase II Study of Weekly Oral Methotrexate and Zidovudine (AZT) in Advanced Adenocarcinoma of the Pancreas and Hepatocellular Carcinoma

Trial Locations

All sites in which the trial HCRN-GI91-1 being conducted in.

No data was found